Form 8-K - Current report:
SEC Accession No. 0001659617-19-000170
Filing Date
2019-11-12
Accepted
2019-11-12 06:33:27
Documents
4
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k93019earningsrelease.htm 8-K 18650
2 EXHIBIT 99.1 exh991-financials93019.htm EX-99.1 66594
3 moleculin-logo_horiza02.jpg GRAPHIC 132868
4 moleculin-logo_horiza07.jpg GRAPHIC 132868
  Complete submission text file 0001659617-19-000170.txt   431267
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 191205914
SIC: 2834 Pharmaceutical Preparations